Page last updated: 2024-12-08

androsterone sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

androsterone sulfate: RN given refers to (3alpha,5alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

androsterone sulfate : A steroid sulfate that is the 3-sulfate of androsterone. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID159663
CHEMBL ID2074598
CHEBI ID83037
SCHEMBL ID235684
MeSH IDM0087913

Synonyms (30)

Synonym
LMST05020001
5alpha-androstane-3alpha-ol-17-one sulfate
3alpha-hydroxy-5alpha-androstan-17-one 3-sulfate
androsterone sulfate
2479-86-9
androsterone, hydrogen sulfate
3alpha-sulfate-5alpha-androstan-17-one
uk5m12z93j ,
3alpha-hydroxy-5alpha-androstan-17-one monosulfate
3alpha-hydroxy-5alpha-androstan-17-one sulfate
unii-uk5m12z93j
5alpha-androsterone sulfate
andros-s
androstan-17-one, 3-(sulfooxy)-, (3alpha,5alpha)-
androsterone 3alpha-sulfate
androsterone monosulfate
bdbm50420249
CHEMBL2074598 ,
chebi:83037 ,
SCHEMBL235684
(5alpha)-17-oxoandrostan-3alpha-yl hydrogen sulfate
3.alpha.-hydroxy-5.alpha.-androstan-17-one monosulfate
androstan-17-one, 3-(sulfooxy)-, (3.alpha.,5.alpha.)-
androsterone 3alpha-sulphate
5alpha-androsterone sulphate
androsterone sulphate
androsterone monosulphate
Q27156586
DTXSID401315288
androstan-17-one, 3-(sulfooxy)-, (3?,5?)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
17-oxo steroidAny oxo steroid carrying the oxo group at position 17.
steroid sulfateA sulfuric ester obtained by the formal condensation of a hydroxy group of any steroid with sulfuric acid.
androstanoidAny steroid based on an androstane skeleton and its derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier organic anion transporter family member 1A1Rattus norvegicus (Norway rat)Ki2.40001.10004.51259.8000AID681147
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID681147TP_TRANSPORTER: inhibition of E217betaG uptake in Oatp1-expressing HeLa cells1996The American journal of physiology, Feb, Volume: 270, Issue:2 Pt 2
Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (31.03)18.7374
1990's6 (20.69)18.2507
2000's3 (10.34)29.6817
2010's8 (27.59)24.3611
2020's3 (10.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.99 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (6.45%)5.53%
Reviews1 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (90.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]